Forvia SE (FRVIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Forvia SE (Forvia) is a manufacturer of automotive equipment. The company designs develops and supplies seat components such as frames, adjustment mechanisms, motors, padding, seat covers, electronic and pneumatic systems and accessories and foams. It also provides vehicle interior products such as instrument panels, modules and door panels, and acoustic products. It manufactures automotive exteriors such as front-end carriers, bumpers, and engine cooling systems. The company develops emission control technologies for light and commercial vehicles. The company operates through manufacturing sites and research and development centers in countries across Europe, the Americas, Africa, and Asia. Forvia is headquartered in Nanterre, Ile-de-France, France.Forvia SE Key Recent Developments
- Jun 03, 2026: Climate and Biodiversity Awards: Final Edition
- May 21, 2026: University of Alicante Brings Together More Than 120 Executives at HR Meeting 2026 to Strengthen University-Business Alliance
- Feb 18, 2026: FORVIA Showcases Innovations for Construction and Mining at CONEXPO-CON/AGG
- Feb 10, 2026: FORVIA Appoints Sébastien Limousin as Executive Vice President of Seating
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
- bioMerieux SA Company Overview
- bioMerieux SA Company Snapshot
- bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
- bioMerieux SA - Pipeline Analysis Overview
- Business Description
- bioMerieux SA - Key Facts
- bioMerieux SA - Major Products and Services
- bioMerieux SA Pipeline Products by Development Stage
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA Pipeline Products Overview
- Annexin A3 Prostate Cancer Marker
- Annexin A3 Prostate Cancer Marker Product Overview
- BIOFIRE FILMARRAY TF Panel
- BIOFIRE FILMARRAY TF Panel Product Overview
- BIOFIRE R/ST PANEL
- BIOFIRE R/ST PANEL Product Overview
- BIOFIRE SPOTFIRE Vaginitis Panel
- BIOFIRE SPOTFIRE Vaginitis Panel Product Overview
- Biomarker Test - Chronic Q Fever
- Biomarker Test - Chronic Q Fever Product Overview
- BRAF - Breast Cancer Diagnostic Kit
- BRAF - Breast Cancer Diagnostic Kit Product Overview
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Overview
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Overview
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Overview
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Overview
- Diagnostic Assay - Prostate Cancer
- Diagnostic Assay - Prostate Cancer Product Overview
- Hylia
- Hylia Product Overview
- iMAG
- iMAG Product Overview
- ISIT-TB Assay
- ISIT-TB Assay Product Overview
- ISIT-TB Assay Clinical Trial
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview
- NucliSENS EasyQ Legionella spp Molecular Test
- NucliSENS EasyQ Legionella spp Molecular Test Product Overview
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview
- Totem
- Totem Product Overview
- VIDAS CXCL9 CDx
- VIDAS CXCL9 CDx Product Overview
- Vidas hsCRP Assay
- Vidas hsCRP Assay Product Overview
- VIDAS TBI - Children
- VIDAS TBI - Children Product Overview
- bioMerieux SA - Key Competitors
- bioMerieux SA - Key Employees
- bioMerieux SA - Key Employee Biographies
- bioMerieux SA - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- bioMerieux SA, Recent Developments
- Jul 14, 2026: bioMérieux to Showcase Company's Latest in Diagnostic Innovations at ADLM 2026
- Jul 08, 2026: bioMérieux Launches PCR Testing Solution to Verify Probiotic Species in Dietary Supplements Manufacturing
- Jun 26, 2026: Advancing Women’s Health with Rapid Diagnostics: bioMérieux Files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE SPOTFIRE Vaginitis Panel
- Jun 18, 2026: BioMerieux Introduces Salmonella Testing Kit on Gene-up Typer to Support Root Cause Analysis in the Food Industry
- May 29, 2026: Biomerieux Invests in France With a New Facility to Produce Innovative Diagnostics for the European Market
- May 29, 2026: BioMérieux Invests €250 Million in French Diagnostic Facility
- May 01, 2026: bioMerieux Receives 510(K) Clearance For ETEST Gepotidacin (GEP) (0.016-256 µg/mL)
- Apr 23, 2026: bioMerieux Releases First-Quarter 2026 Business Review
- Apr 23, 2026: bioMerieux Announces First-Quarter 2026 Business Review
- Apr 20, 2026: First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- bioMerieux SA Pipeline Products and Ongoing Clinical Trials Overview
- bioMerieux SA Pipeline Products by Equipment Type
- bioMerieux SA Pipeline Products by Indication
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA, Key Facts
- bioMerieux SA, Major Products and Services
- bioMerieux SA Number of Pipeline Products by Development Stage
- bioMerieux SA Pipeline Products Summary by Development Stage
- bioMerieux SA Ongoing Clinical Trials by Trial Status
- bioMerieux SA Ongoing Clinical Trials Summary
- Annexin A3 Prostate Cancer Marker - Product Status
- Annexin A3 Prostate Cancer Marker - Product Description
- BIOFIRE FILMARRAY TF Panel - Product Status
- BIOFIRE FILMARRAY TF Panel - Product Description
- BIOFIRE R/ST PANEL - Product Status
- BIOFIRE R/ST PANEL - Product Description
- BIOFIRE SPOTFIRE Vaginitis Panel - Product Status
- BIOFIRE SPOTFIRE Vaginitis Panel - Product Description
- Biomarker Test - Chronic Q Fever - Product Status
- Biomarker Test - Chronic Q Fever - Product Description
- BRAF - Breast Cancer Diagnostic Kit - Product Status
- BRAF - Breast Cancer Diagnostic Kit - Product Description
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
- Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status
- Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status
- Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
- Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
- Diagnostic Assay - Prostate Cancer - Product Status
- Diagnostic Assay - Prostate Cancer - Product Description
- Hylia - Product Status
- Hylia - Product Description
- iMAG - Product Status
- iMAG - Product Description
- ISIT-TB Assay - Product Status
- ISIT-TB Assay - Product Description
- ISIT-TB Assay - Early Risk Assessment in TB Contacts by New Diagnostic Tests
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status
- NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description
- NucliSENS EasyQ Legionella spp Molecular Test - Product Status
- NucliSENS EasyQ Legionella spp Molecular Test - Product Description
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Status
- NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Description
- Totem - Product Status
- Totem - Product Description
- VIDAS CXCL9 CDx - Product Status
- VIDAS CXCL9 CDx - Product Description
- Vidas hsCRP Assay - Product Status
- Vidas hsCRP Assay - Product Description
- VIDAS TBI - Children - Product Status
- VIDAS TBI - Children - Product Description
- bioMerieux SA, Key Employees
- bioMerieux SA, Key Employee Biographies
- bioMerieux SA, Other Locations
- bioMerieux SA, Subsidiaries
- Glossary
- bioMerieux SA Pipeline Products by Equipment Type
- bioMerieux SA Pipeline Products by Development Stage
- bioMerieux SA Ongoing Clinical Trials by Trial Status
